| Product Code: ETC6736389 | Publication Date: Sep 2024 | Updated Date: Oct 2025 | Product Type: Market Research Report | |
| Publisher: 6Wresearch | Author: Summon Dutta | No. of Pages: 75 | No. of Figures: 35 | No. of Tables: 20 |
China amitriptyline import market in 2024 continues to be dominated by key exporting countries such as Ireland, Indonesia, UK, India, and Metropolitan France. Despite a negative compound annual growth rate (CAGR) of -6.23% from 2020 to 2024, the market saw a slight growth rate of 0.01% from 2023 to 2024. The High Herfindahl-Hirschman Index (HHI) indicates a high concentration within the market, reflecting the competitive landscape among the top exporting countries. This data suggests a stable yet competitive environment for amitriptyline imports into China.

1 Executive Summary |
2 Introduction |
2.1 Key Highlights of the Report |
2.2 Report Description |
2.3 Market Scope & Segmentation |
2.4 Research Methodology |
2.5 Assumptions |
3 China Amitriptyline Market Overview |
3.1 China Country Macro Economic Indicators |
3.2 China Amitriptyline Market Revenues & Volume, 2021 & 2031F |
3.3 China Amitriptyline Market - Industry Life Cycle |
3.4 China Amitriptyline Market - Porter's Five Forces |
3.5 China Amitriptyline Market Revenues & Volume Share, By Strength, 2021 & 2031F |
3.6 China Amitriptyline Market Revenues & Volume Share, By Application, 2021 & 2031F |
3.7 China Amitriptyline Market Revenues & Volume Share, By Demographic, 2021 & 2031F |
3.8 China Amitriptyline Market Revenues & Volume Share, By Dosage Form, 2021 & 2031F |
3.9 China Amitriptyline Market Revenues & Volume Share, By Route of Administration, 2021 & 2031F |
3.10 China Amitriptyline Market Revenues & Volume Share, By End-Users, 2021 & 2031F |
3.11 China Amitriptyline Market Revenues & Volume Share, By Distribution Channel, 2021 & 2031F |
4 China Amitriptyline Market Dynamics |
4.1 Impact Analysis |
4.2 Market Drivers |
4.2.1 Increasing prevalence of depression and anxiety disorders in China |
4.2.2 Growing awareness about mental health and the need for treatment |
4.2.3 Rising geriatric population in China requiring treatment for chronic pain and depression |
4.3 Market Restraints |
4.3.1 Stringent regulations and approval processes for pharmaceutical products in China |
4.3.2 Competition from alternative treatments such as therapy and other medications |
4.3.3 Potential side effects and risks associated with amitriptyline impacting adoption rates |
5 China Amitriptyline Market Trends |
6 China Amitriptyline Market, By Types |
6.1 China Amitriptyline Market, By Strength |
6.1.1 Overview and Analysis |
6.1.2 China Amitriptyline Market Revenues & Volume, By Strength, 2021- 2031F |
6.1.3 China Amitriptyline Market Revenues & Volume, By 10mg, 2021- 2031F |
6.1.4 China Amitriptyline Market Revenues & Volume, By 25mg, 2021- 2031F |
6.1.5 China Amitriptyline Market Revenues & Volume, By 50mg, 2021- 2031F |
6.1.6 China Amitriptyline Market Revenues & Volume, By 75mg, 2021- 2031F |
6.1.7 China Amitriptyline Market Revenues & Volume, By 100mg, 2021- 2031F |
6.1.8 China Amitriptyline Market Revenues & Volume, By 150mg, 2021- 2031F |
6.2 China Amitriptyline Market, By Application |
6.2.1 Overview and Analysis |
6.2.2 China Amitriptyline Market Revenues & Volume, By Migraine, 2021- 2031F |
6.2.3 China Amitriptyline Market Revenues & Volume, By Nocturnal Enuresis, 2021- 2031F |
6.2.4 China Amitriptyline Market Revenues & Volume, By Chronic Neuropathic Pain, 2021- 2031F |
6.2.5 China Amitriptyline Market Revenues & Volume, By Depression, 2021- 2031F |
6.2.6 China Amitriptyline Market Revenues & Volume, By Others, 2021- 2031F |
6.3 China Amitriptyline Market, By Demographic |
6.3.1 Overview and Analysis |
6.3.2 China Amitriptyline Market Revenues & Volume, By Adult, 2021- 2031F |
6.3.3 China Amitriptyline Market Revenues & Volume, By Pediatric, 2021- 2031F |
6.3.4 China Amitriptyline Market Revenues & Volume, By Geriatric, 2021- 2031F |
6.4 China Amitriptyline Market, By Dosage Form |
6.4.1 Overview and Analysis |
6.4.2 China Amitriptyline Market Revenues & Volume, By Tablet, 2021- 2031F |
6.4.3 China Amitriptyline Market Revenues & Volume, By Injection, 2021- 2031F |
6.4.4 China Amitriptyline Market Revenues & Volume, By Others, 2021- 2031F |
6.5 China Amitriptyline Market, By Route of Administration |
6.5.1 Overview and Analysis |
6.5.2 China Amitriptyline Market Revenues & Volume, By Oral, 2021- 2031F |
6.5.3 China Amitriptyline Market Revenues & Volume, By IntramusculaR, 2021- 2031F |
6.5.4 China Amitriptyline Market Revenues & Volume, By Others, 2021- 2031F |
6.6 China Amitriptyline Market, By End-Users |
6.6.1 Overview and Analysis |
6.6.2 China Amitriptyline Market Revenues & Volume, By Clinic, 2021- 2031F |
6.6.3 China Amitriptyline Market Revenues & Volume, By Hospital, 2021- 2031F |
6.6.4 China Amitriptyline Market Revenues & Volume, By Others, 2021- 2031F |
6.7 China Amitriptyline Market, By Distribution Channel |
6.7.1 Overview and Analysis |
6.7.2 China Amitriptyline Market Revenues & Volume, By Hospital Pharmacy, 2021- 2031F |
6.7.3 China Amitriptyline Market Revenues & Volume, By Retail Pharmacy, 2021- 2031F |
6.7.4 China Amitriptyline Market Revenues & Volume, By , 2021- 2031F |
7 China Amitriptyline Market Import-Export Trade Statistics |
7.1 China Amitriptyline Market Export to Major Countries |
7.2 China Amitriptyline Market Imports from Major Countries |
8 China Amitriptyline Market Key Performance Indicators |
8.1 Prescription rates of amitriptyline by healthcare providers in China |
8.2 Patient adherence and compliance rates to amitriptyline treatment |
8.3 Number of clinical trials and research studies conducted on the efficacy and safety of amitriptyline in China |
9 China Amitriptyline Market - Opportunity Assessment |
9.1 China Amitriptyline Market Opportunity Assessment, By Strength, 2021 & 2031F |
9.2 China Amitriptyline Market Opportunity Assessment, By Application, 2021 & 2031F |
9.3 China Amitriptyline Market Opportunity Assessment, By Demographic, 2021 & 2031F |
9.4 China Amitriptyline Market Opportunity Assessment, By Dosage Form, 2021 & 2031F |
9.5 China Amitriptyline Market Opportunity Assessment, By Route of Administration, 2021 & 2031F |
9.6 China Amitriptyline Market Opportunity Assessment, By End-Users, 2021 & 2031F |
9.7 China Amitriptyline Market Opportunity Assessment, By Distribution Channel, 2021 & 2031F |
10 China Amitriptyline Market - Competitive Landscape |
10.1 China Amitriptyline Market Revenue Share, By Companies, 2024 |
10.2 China Amitriptyline Market Competitive Benchmarking, By Operating and Technical Parameters |
11 Company Profiles |
12 Recommendations |
13 Disclaimer |
Export potential enables firms to identify high-growth global markets with greater confidence by combining advanced trade intelligence with a structured quantitative methodology. The framework analyzes emerging demand trends and country-level import patterns while integrating macroeconomic and trade datasets such as GDP and population forecasts, bilateral import–export flows, tariff structures, elasticity differentials between developed and developing economies, geographic distance, and import demand projections. Using weighted trade values from 2020–2024 as the base period to project country-to-country export potential for 2030, these inputs are operationalized through calculated drivers such as gravity model parameters, tariff impact factors, and projected GDP per-capita growth. Through an analysis of hidden potentials, demand hotspots, and market conditions that are most favorable to success, this method enables firms to focus on target countries, maximize returns, and global expansion with data, backed by accuracy.
By factoring in the projected importer demand gap that is currently unmet and could be potential opportunity, it identifies the potential for the Exporter (Country) among 190 countries, against the general trade analysis, which identifies the biggest importer or exporter.
To discover high-growth global markets and optimize your business strategy:
Click Here